Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group
- PMID: 11182983
- PMCID: PMC4307402
- DOI: 10.1161/01.cir.102.13.1542
Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group
Abstract
Background: Left ventricular (LV) dysfunction is common in children infected with the human immunodeficiency virus (HIV), but its clinical importance is unclear. Our objective was to determine whether abnormalities of LV structure and function independently predict all-cause mortality in HIV-infected children.
Methods and results: Baseline echocardiograms were obtained on 193 children with vertically transmitted HIV infection (median age, 2.1 years). Children were followed up for a median of 5 years. Cox regression was used to identify measures of LV structure and function predictive of mortality after adjustment for other important demographic and baseline clinical risk factors. The time course of cardiac variables before mortality was also examined. The 5-year cumulative survival was 64%. Mortality was higher in children who, at baseline, had depressed LV fractional shortening (FS) or contractility; increased LV dimension, thickness, mass, or wall stress; or increased heart rate or blood pressure (P0.02 for each). Decreased LV FS (P<0.001) and increased wall thickness (P=0.004) were also predictive of increased mortality after adjustment for CD4 count (P<0.001), clinical center (P<0.001), and encephalopathy (P<0.001). FS showed abnormalities for up to 3 years before death, whereas wall thickness identified a population at risk only 18 to 24 months before death.
Conclusions: Depressed LV FS and increased wall thickness are risk factors for mortality in HIV-infected children independent of depressed CD4 cell count and neurological disease. FS may be useful as a long-term predictor and wall thickness as a short-term predictor of mortality.
Figures
References
-
- Lipshultz SE, Easley KA, Orav EJ, et al. for the Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group LV structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV multicenter study. Circulation. 1998;97:1246–56. - PMC - PubMed
-
- Starc TJ, Lipshultz SE, Kaplan S, et al. for the Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group Cardiac complications in children with human immunodeficiency virus infection. Pediatrics. 1999;104:2, e14. URL: http://www.pediatrics.org/cgi/content/full/104/2/e14. - PMC - PubMed
-
- Moorthy LN, Lipshultz SE. Cardiovascular monitoring of HIV-infected patients. In: Lipshultz SE, editor. Cardiology in AIDS. New York, NY: Chapman & Hall; 1998. pp. 345–84.
-
- Devereux RB, Alonso DR, Lutas EM. Echocardiographic assessment of LV hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–8. - PubMed
Publication types
MeSH terms
Grants and funding
- K01 RR000188/RR/NCRR NIH HHS/United States
- M01 RR000645/RR/NCRR NIH HHS/United States
- N01-HR-96039/HR/NHLBI NIH HHS/United States
- M01 RR000865/RR/NCRR NIH HHS/United States
- M01 RR000533/RR/NCRR NIH HHS/United States
- N01 HR096037/HR/NHLBI NIH HHS/United States
- M01 RR002172/RR/NCRR NIH HHS/United States
- M01 RR000188/RR/NCRR NIH HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- M01 RR000043/RR/NCRR NIH HHS/United States
- N01-HR-96038/HR/NHLBI NIH HHS/United States
- N01 HR096043/HR/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
